Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Career Fair

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 20 July 1990:
Vol. 249. no. 4966, pp. 277 - 280
DOI: 10.1126/science.2374926

Articles

Science, Vol 249, Issue 4966, 277-280
Copyright © 1990 by American Association for the Advancement of Science


articles

The structure of a complex of recombinant hirudin and human alpha-thrombin

TJ Rydel, KG Ravichandran, A Tulinsky, W Bode, R Huber, C Roitsch, and JW Fenton 2nd

Department of Chemistry, Michigan State University, East Lansing 48824.

The crystallographic structure of a recombinant hirudin-thrombin complex has been solved at 2.3 angstrom (A) resolution. Hirudin consists of an NH2-terminal globular domain and a long (39 A) COOH-terminal extended domain. Residues Ile1 to Tyr3 of hirudin form a parallel beta-strand with Ser214 to Glu217 of thrombin with the nitrogen atom of Ile1 making a hydrogen bond with Ser195 O gamma atom of the catalytic site, but the specificity pocket of thrombin is not involved in the interaction. The COOH-terminal segment makes numerous electrostatic interactions with an anion-binding exosite of thrombin, whereas the last five residues are in a helical loop that forms many hydrophobic contacts. In all, 27 of the 65 residues of hirudin have contacts less than 4.0 A with thrombin (10 ion pairs and 23 hydrogen bonds). Such abundant interactions may account for the high affinity and specificity of hirudin.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Variegin, a Novel Fast and Tight Binding Thrombin Inhibitor from the Tropical Bont Tick.
C. Y. Koh, M. Kazimirova, A. Trimnell, P. Takac, M. Labuda, P. A. Nuttall, and R. M. Kini (2007)
J. Biol. Chem. 282, 29101-29113
   Abstract »    Full Text »    PDF »
Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.
P. Arora, T. K. Ricks, and J. Trejo (2007)
J. Cell Sci. 120, 921-928
   Abstract »    Full Text »    PDF »
Novel Fluorescent Prothrombin Analogs as Probes of Staphylocoagulase-Prothrombin Interactions.
P. Panizzi, R. Friedrich, P. Fuentes-Prior, H. K. Kroh, J. Briggs, G. Tans, W. Bode, and P. E. Bock (2006)
J. Biol. Chem. 281, 1169-1178
   Abstract »    Full Text »    PDF »
Direct Thrombin Inhibitors.
M. Di Nisio, S. Middeldorp, and H. R. Buller (2005)
N. Engl. J. Med. 353, 1028-1040
   Full Text »    PDF »
Exosite-interactive Regions in the A1 and A2 Domains of Factor VIII Facilitate Thrombin-catalyzed Cleavage of Heavy Chain.
K. Nogami, Q. Zhou, T. Myles, L. L. K. Leung, H. Wakabayashi, and P. J. Fay (2005)
J. Biol. Chem. 280, 18476-18487
   Abstract »    Full Text »    PDF »
Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis.
L. Hu, M. Lee, W. Campbell, R. Perez-Soler, and S. Karpatkin (2004)
Blood 104, 2746-2751
   Abstract »    Full Text »    PDF »
Proexosite-1-dependent Recognition and Activation of Prothrombin by Taipan Venom.
L. Chen and A. R. Rezaie (2004)
J. Biol. Chem. 279, 17869-17874
   Abstract »    Full Text »    PDF »
Crystal structure of the complex between thrombin and the central "E" region of fibrin.
I. Pechik, J. Madrazo, M. W. Mosesson, I. Hernandez, G. L. Gilliland, and L. Medved (2004)
PNAS 101, 2718-2723
   Abstract »    Full Text »    PDF »
Streptomyces griseus Trypsin Is Stabilized against Autolysis by the Cooperation of a Salt Bridge and Cation-{pi} Interaction.
W. S. Lee, C. H. Park, and S. M. Byun (2004)
J. Biochem. 135, 93-99
   Abstract »    Full Text »    PDF »
Thrombin Activation of Factor XI on Activated Platelets Requires the Interaction of Factor XI and Platelet Glycoprotein Ib{alpha} with Thrombin Anion-binding Exosites I and II, Respectively.
T. H. Yun, F. A. Baglia, T. Myles, D. Navaneetham, J. A. Lopez, P. N. Walsh, and L. L. K. Leung (2003)
J. Biol. Chem. 278, 48112-48119
   Abstract »    Full Text »    PDF »
Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin.
A. R. Rezaie and L. Yang (2003)
PNAS 100, 12051-12056
   Abstract »    Full Text »    PDF »
Emerging Anticoagulant Drugs.
S. M. Bates and J. I. Weitz (2003)
Arterioscler. Thromb. Vasc. Biol. 23, 1491-1500
   Abstract »    Full Text »    PDF »
Human Rhinovirus 2 2Apro Recognition of Eukaryotic Initiation Factor 4GI: INVOLVEMENT OF AN EXOSITE.
N. Foeger, E. M. Schmid, and T. Skern (2003)
J. Biol. Chem. 278, 33200-33207
   Abstract »    Full Text »    PDF »
Proexosite-1 on Prothrombin Is a Factor Va-dependent Recognition Site for the Prothrombinase Complex.
L. Chen, L. Yang, and A. R. Rezaie (2003)
J. Biol. Chem. 278, 27564-27569
   Abstract »    Full Text »    PDF »
Crystal Structure of the GpIb{alpha}-Thrombin Complex Essential for Platelet Aggregation.
J. J. Dumas, R. Kumar, J. Seehra, W. S. Somers, and L. Mosyak (2003)
Science 301, 222-226
   Abstract »    Full Text »    PDF »
Thrombolytic Therapy.
W. F. Baker Jr (2002)
Clinical and Applied Thrombosis/Hemostasis 8, 291-314
   PDF »
Structural requirements for the activation of human factor VIII by thrombin.
T. Myles, T. H. Yun, and L. L. K. Leung (2002)
Blood 100, 2820-2826
   Abstract »    Full Text »    PDF »
Crystal Structure of the Platelet Glycoprotein Ibalpha N-terminal Domain Reveals an Unmasking Mechanism for Receptor Activation.
S. Uff, J. M. Clemetson, T. Harrison, K. J. Clemetson, and J. Emsley (2002)
J. Biol. Chem. 277, 35657-35663
   Abstract »    Full Text »    PDF »
Increased thrombogenesis and embolus formation in mice lacking glycoprotein V.
H. Ni, V. Ramakrishnan, Z. M. Ruggeri, J. M. Papalia, D. R. Phillips, and D. D. Wagner (2001)
Blood 98, 368-373
   Abstract »    Full Text »    PDF »
New Tricks for Old Dogs : Nonthrombotic Effects of Thrombin in Vessel Wall Biology.
C. Patterson, G. A. Stouffer, N. Madamanchi, and M. S. Runge (2001)
Circ. Res. 88, 987-997
   Abstract »    Full Text »    PDF »
Drug-Related Adverse Events: A Readers' Guide to Assessing Literature Reviews and Meta-analyses.
S. D. Ross (2001)
Arch Intern Med 161, 1041-1046
   Full Text »    PDF »
New Anticoagulant Drugs.
J. I. Weitz and J. Hirsh (2001)
Chest 119, 95S-107S
   Full Text »    PDF »
Intravenous Thrombolysis in Acute Myocardial Infarction.
E. M. Ohman, R. A. Harrington, C. P. Cannon, G. Agnelli, J. A. Cairns, and J.W. Kennedy (2001)
Chest 119, 253S-277S
   Full Text »    PDF »
Vascular Contraction and Relaxation to Thrombin and Trypsin: Thrombomodulin Preferentially Attenuates Thrombin-Induced Contraction.
A. Bhattacharya and M. L. Cohen (2000)
J. Pharmacol. Exp. Ther. 295, 284-290
   Abstract »    Full Text »
Elimination of Recombinant Hirudin by Modified Ultrafiltration During Simulated Cardiopulmonary Bypass: Assessment of Different Filter Systems.
A. Koster, F. Merkle, R. Hansen, M. Loebe, H. Kuppe, R. Hetzer, G. J. Crystal, and F. Mertzlufft (2000)
Anesth. Analg. 91, 265-269
   Abstract »    Full Text »    PDF »
The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites.
A. J. Gale, M. J. Heeb, and J. H. Griffin (2000)
Blood 96, 585-593
   Abstract »    Full Text »    PDF »
Protease-activated Receptor 1 Mediates Thrombin-dependent, Cell-mediated Renal Inflammation in Crescentic Glomerulonephritis.
M. A. Cunningham, E. Rondeau, X. Chen, S. R. Coughlin, S. R. Holdsworth, and P. G. Tipping (2000)
J. Exp. Med. 191, 455-462
   Abstract »    Full Text »    PDF »
Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism.
J. E. Ansell, J. I. Weitz, and A. J. Comerota (2000)
Hematology 2000, 266-284
   Abstract »    Full Text »    PDF »
Reduction in Vascular Lesion Formation by Hirudin Secreted From Retrovirus-Transduced Confluent Endothelial Cells on Vascular Grafts in Baboons.
A. Lundell, A. B. Kelly, J. Anderson, M. Marijianowski, J. J. Rade, S. R. Hanson, and L. A. Harker (1999)
Circulation 100, 2018-2024
   Abstract »    Full Text »    PDF »
Prevention of activation of blood coagulation during acute coronary ischemic syndromes: beyond aspirin and heparin.
S. M. Bates and J. I. Weitz (1999)
Cardiovasc Res 41, 418-432
   Abstract »    Full Text »    PDF »
The Platelet High Affinity Binding Site for Thrombin Mimics Hirudin, Modulates Thrombin-induced Platelet Activation, and Is Distinct from the Glycoprotein Ib-IX-V Complex.
K. L. Hayes and P. B. Tracy (1999)
J. Biol. Chem. 274, 972-980
   Abstract »    Full Text »    PDF »
Tsetse thrombin inhibitor: Bloodmeal-induced expression of an anticoagulant in salivary glands and gut tissue of Glossina morsitans morsitans.
M. Cappello, S. Li, X. Chen, C.-B. Li, L. Harrison, S. Narashimhan, C. B. Beard, and S. Aksoy (1998)
PNAS 95, 14290-14295
   Abstract »    Full Text »    PDF »
Sol Sherry Lecture in Thrombosis : How Thrombin `Talks' to Cells Molecular Mechanisms and Roles In Vivo.
S. R. Coughlin (1998)
Arterioscler. Thromb. Vasc. Biol. 18, 514-518
   Full Text »    PDF »
Thrombin Binds to Soluble Fibrin Degradation Products Where it Is Protected From Inhibition by Heparin-Antithrombin but Susceptible to Inactivation by Antithrombin-Independent Inhibitors.
J. I. Weitz, B. Leslie, and M. Hudoba (1998)
Circulation 97, 544-552
   Abstract »    Full Text »    PDF »
Inhibition of Meizothrombin and Meizothrombin(desF1) by Heparin Cofactor II.
J.-H. Han, H. C. F. Cote, and D. M. Tollefsen (1997)
J. Biol. Chem. 272, 28660-28665
   Abstract »    Full Text »    PDF »
Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug.
P. Fuentes-Prior, C. Noeske-Jungblut, P. Donner, W.-D. Schleuning, R. Huber, and W. Bode (1997)
PNAS 94, 11845-11850
   Abstract »    Full Text »    PDF »
Structure-based Design of a Potent Chimeric Thrombin Inhibitor.
R. Morenweiser, E. A. Auerswald, A. van de Locht, H. Fritz, J. Sturzebecher, and M. T. Stubbs (1997)
J. Biol. Chem. 272, 19938-19942
   Abstract »    Full Text »    PDF »
Potent Antithrombin Activity and Delayed Clearance From the Circulation Characterize Recombinant Hirudin Genetically Fused to Albumin.
S. Syed, P. D. Schuyler, M. Kulczycky, and W. P. Sheffield (1997)
Blood 89, 3243-3252
   Abstract »    Full Text »    PDF »
Heparin Facilitates Dissociation of Complexes between Thrombin and a Reactive Site Mutant (L444R) of Heparin Cofactor II.
J.-H. Han, V. M.D. Van Deerlin, and D. M. Tollefsen (1997)
J. Biol. Chem. 272, 8243-8249
   Abstract »    Full Text »    PDF »
Binding of Fibrin Monomer and Heparin to Thrombin in a Ternary Complex Alters the Environment of the Thrombin Catalytic Site, Reduces Affinity for Hirudin, and Inhibits Cleavage of Fibrinogen.
P. J. Hogg, C. M. Jackson, J. K. Labanowski, and P. E. Bock (1996)
J. Biol. Chem. 271, 26088-26095
   Abstract »    Full Text »    PDF »
Rational Design, Recombinant Preparation, and in Vitro and in Vivo Characterization of Human Prothrombin-derived Hirudin Antagonists.
B. E. Fischer, U. Schlokat, A. Mitterer, H. Savidis-Dacho, L. Grillberger, M. Reiter, W. Mundt, F. Dorner, and J. Eibl (1996)
J. Biol. Chem. 271, 23737-23742
   Abstract »    Full Text »    PDF »
Role of Residue 99at the S2 Subsite of Factor Xa and Activated Protein C in Enzyme Specificity.
A. R. Rezaie and A. R. Rezaie (1996)
J. Biol. Chem. 271, 23807-23814
   Abstract »    Full Text »    PDF »
Identification and Characterization of the Thrombin Binding Sites on Fibrin.
D. A. Meh, K. R. Siebenlist, and M. W. Mosesson (1996)
J. Biol. Chem. 271, 23121-23125
   Abstract »    Full Text »    PDF »
Hirudin in Acute Myocardial Infarction: Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B Trial.
E. M. Antman (1996)
Circulation 94, 911-921
   Abstract »    Full Text »
Enhanced Thrombin Sensitivity of a Factor VIII-Heparin Cofactor II Hybrid.
J. Voorberg, G. van Stempvoort, J. M.K. Bos, K. Mertens, J. A. van Mourik, and M.-J. S.H. Donath (1996)
J. Biol. Chem. 271, 20985-20988
   Abstract »    Full Text »    PDF »
Transcriptional Activation Domain of the Herpesvirus Protein VP16 Becomes Conformationally Constrained upon Interaction with Basal Transcription Factors.
F. Shen, S. J. Triezenberg, P. Hensley, D. Porter, and J. R. Knutson (1996)
J. Biol. Chem. 271, 4827-4837
   Abstract »    Full Text »    PDF »
Triabin, a Highly Potent Exosite Inhibitor of Thrombin.
C. Noeske-Jungblut, B. Haendler, P. Donner, A. Alagon, L. Possani, and W.-D. Schleuning (1995)
J. Biol. Chem. 270, 28629-28634
   Abstract »    Full Text »    PDF »
Thrombin and Proliferation of Vascular Smooth Muscle Cells.
G. Fager (1995)
Circ. Res. 77, 645-650
   Full Text »
Immunoselective Targeting of an Anti-Thrombin Agent to the Surface of Cytokine-Activated Vascular Endothelial Cells.
J.-M. Kiely, M. I. Cybulsky, F. W. Luscinskas, and M. A. Gimbrone Jr (1995)
Arterioscler. Thromb. Vasc. Biol. 15, 1211-1218
   Abstract »    Full Text »
Functional Mapping of the Surface Residues of Human Thrombin.
M. Tsiang, A. K. Jain, K. E. Dunn, M. E. Rojas, L. L. K. Leung, and C. S. Gibbs (1995)
J. Biol. Chem. 270, 16854-16863
   Abstract »    Full Text »    PDF »
Determinants of Thrombin Receptor Cleavage.
K. Ishii, R. Gerszten, Y. W. Zheng, J. B. Welsh, C. W. Turck, and S. R. Coughlin (1995)
J. Biol. Chem. 270, 16435-16440
   Abstract »    Full Text »    PDF »
The Disulfide Structures of Scrambled Hirudins.
J.-Y. Chang, P. Schindler, and B. Chatrenet (1995)
J. Biol. Chem. 270, 11992-11997
   Abstract »    Full Text »    PDF »
Identification of Three Tyrosine Residues of Glycoprotein Ib[IMAGE] with Distinct Roles in von Willebrand Factor and [IMAGE]-Thrombin Binding.
P. Marchese, M. Murata, M. Mazzucato, P. Pradella, L. D. Marco, J. Ware, and Z. M. Ruggeri (1995)
J. Biol. Chem. 270, 9571-9578
   Abstract »    Full Text »    PDF »
Fibrinolytic Compromise by Synthetic and Recombinant Thrombin Inhibitors: Implications in the Treatment of Thrombotic Disorders.
D. D. Callas, O. Iqbal, D. Hoppensteadt, and J. Fareed (1995)
Clinical and Applied Thrombosis/Hemostasis 1, 114-124
   Abstract »    PDF »
Structure of the RGD protein decorsin: conserved motif and distinct function in leech proteins that affect blood clotting.
A. Krezel, G Wagner, J Seymour-Ulmer, and R. Lazarus (1994)
Science 264, 1944-1947
   Abstract »    PDF »
Interaction of the Factor XIII Activation Peptide with alpha -Thrombin. CRYSTAL STRUCTURE OF ITS ENZYME-SUBSTRATE ANALOG COMPLEX.
C. Sadasivan and V. C. Yee (2000)
J. Biol. Chem. 275, 36942-36948
   Abstract »    Full Text »    PDF »
An Extensive Interaction Interface between Thrombin and Factor V Is Required for Factor V Activation.
T. Myles, T. H. Yun, S. W. Hall, and L. L. K. Leung (2001)
J. Biol. Chem. 276, 25143-25149
   Abstract »    Full Text »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)